Compared to peritoneal mesothelioma, MPM harbour more frequent loss of CDKN2A, and loss of CDKN2A has been linked to resistance to immunotherapy in non-small cell lung cancer [77]. The gene discussed is CDKN2A; the disease is non-small cell lung carcinoma.